Gilead CAR-T on partial clinical hold; Agios' PDUFA date pushed back
Plus news about Acumen, Bristol Myers Squibb, Regeneron, Aer Therapeutics and Hemay Pharmaceutical. Gilead pauses CAR-T after ICANS: After several cases of the neurological condition known as ICANS, Gilead said in ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.